Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy

被引：2
作者：
Meyer, Ralph M. [1 ,2 ,3 ,4 ]
Hoppe, Richard T. [5 ]
机构：
[1] Queens Univ, NCIC, Clin Trials Grp, Kingston, ON, Canada
[2] Queens Univ, Dept Oncol, Kingston, ON, Canada
[3] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada
[4] Queens Univ, Dept Commun Hlth & Epidemiol, Kingston, ON K7L 3N6, Canada
[5] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
来源：
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM | 2012年
关键词：
INVOLVED-FIELD RADIOTHERAPY; COMBINED-MODALITY TREATMENT; COMBINATION CHEMOTHERAPY; PRACTICE GUIDELINES; MOPP CHEMOTHERAPY; NODE RADIOTHERAPY; CLINICAL-TRIALS; DISEASE; VINBLASTINE; ABVD;
D O I：
10.1182/asheducation-2012.1.313
中图分类号：
G40 [教育学];
学科分类号：
040101 ; 120403 ;
摘要：
The results of recent clinical trials for the management of limited-stage Hodgkin lymphoma have led to considerable debate, especially regarding the role of radiation therapy. This review highlights those recent trials and provides perspectives regarding their interpretation from a radiation oncologist and a hematologist. The trial protocol is available at http://www.nejm.org/doi/suppl/10.1056/NEJMoa1111961/suppl_file/nejmoa1111961_protocol.pdf.
引用
收藏
页码：313 / 321
页数：9
相关论文
共 50 条
  • [31] Role of Radiation Therapy in the Treatment of Hodgkin Lymphoma
    Gonzalez, Victor J.
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (03) : 244 - 250
  • [32] Radiation Therapy for Advanced-Stage Hodgkin Lymphoma
    Lockney, Natalie A.
    Yang, Joanna C.
    [J]. ADVANCES IN RADIATION ONCOLOGY, 2020, 5 (05) : 809 - 816
  • [33] Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation
    Gunther, Jillian R.
    Fanale, Michelle A.
    Reddy, Jay P.
    Akhtari, Mani
    Smith, Grace L.
    Pinnix, Chelsea C.
    Milgrom, Sarah A.
    Abou Yehia, Zeinab
    Allen, Pamela K.
    Osborne, Eleanor M.
    Mawlawi, Osama
    Dabaja, Bouthaina S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (01): : 110 - 118
  • [34] Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era
    LeMieux, Melissa H.
    Solanki, Abhishek A.
    Mahmood, Usama
    Chmura, Steven J.
    Koshy, Matthew
    [J]. CANCER MEDICINE, 2015, 4 (04): : 513 - 518
  • [35] Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma
    Krebs, Lorraine
    Amorin, Sandy
    Brice, Pauline
    Guillerm, Sophie
    Menard, Jean
    Hennequin, Christophe
    Quero, Laurent
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (02) : 116 - 124
  • [36] The important role of radiation therapy in early-stage diffuse large B-cell lymphoma: time to review the evidence once again
    Bindra, Ranjit S.
    Yahalom, Joachim
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (09) : 1367 - 1378
  • [37] Radiotherapy in early stage Hodgkin lymphoma
    Illidge, Tim
    [J]. HEMATOLOGICAL ONCOLOGY, 2013, 31 : 92 - 95
  • [38] Combined-Modality Therapy for Early-Stage Hodgkin Lymphoma: Maintaining High Cure Rates While Minimizing Risks
    Kelsey, Chris R.
    Beaven, Anne W.
    Diehl, Louis F.
    Prosnitz, Leonard R.
    [J]. ONCOLOGY-NEW YORK, 2012, 26 (12): : 1182 - 1193
  • [39] Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group
    Sasse, Stephanie
    Goergen, Helen
    Pluetschow, Annette
    Boell, Boris
    Eichenauer, Dennis A.
    Fuchs, Michael
    Behringer, Karolin
    Zijlstra, Josee M.
    Greil, Richard
    Markova, Jana
    Topp, Max S.
    Meissner, Julia
    Neubauer, Andreas
    Baues, Christian
    Engert, Andreas
    Borchmann, Peter
    von Tresckow, Bastian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (25) : 2603 - +
  • [40] Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma- a risk stratified analysis of the GHSG HD17 trial
    Oertel, Michael
    Hering, Dominik
    Baues, Christian
    Kittel, Christopher
    Fuchs, Michael
    Kriz, Jan
    Kroeger, Kai
    Vordermark, Dirk
    Herfarth, Klaus
    Engenhart-Cabillic, Rita
    Lukas, Peter
    Haverkamp, Uwe
    Borchmann, Peter
    Eich, Hans Theodor
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
12345